Matches in SemOpenAlex for { <https://semopenalex.org/work/W162371606> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W162371606 endingPage "62" @default.
- W162371606 startingPage "959" @default.
- W162371606 abstract "Serum CA M26 and CA M29 values were determined in 125 women: 46 patients with primary breast cancer, 49 patients with benign breast disease, and 30 controls. The mean CA M26 and CA M29 values in breast cancer patients were higher than in patients with benign breast disease and in control subjects. When we set the cut-off level at 40 kU/1 for CA M26, 15/46 (33%) of all breast cancer patients, 11/20 (55%) of breast cancer patients with axillary node involvement, 1/1 breast cancer patient with distant metastases, 4/49 (8%) of patients with benign breast disease, and 7/30 (23%) of control subjects were above this cut-off level. For comparison, at the cut-off level of 10 kU/1 the CA M29 test was positive in 30/46 (65%) cancer cases, in 16/20 (80%) of cancer patients with nodal involvement, in 9/49 (18%) of the patients with benign breast disease, and in 10/30 (33%) of control subjects. Patients with axillary nodal metastasis showed higher values than patients without metastasis in both tests. When we used a cut-off level of 15 kU/1 for CA M29, 24% (11/46) of all breast cancer patients, 35% (7/20) of breast cancer patients with axillary node involvement, 4% (2/49) of patients with benign breast disease, and 0% of control subjects were above this cut-off level. The combination of CA M26 at the 40 kU/l cut-off level and CA M29 at the 10 kU/l cut-off level reached the diagnostic sensitivity of 0.65, specificity of 0.78, and efficiency of 0.72. In breast cancer detection among patients with breast problems serum marker CA M29 reached the sensitivity of 0.65 at the specificity level of 0.82. Our results suggest that the CA M29 marker alone is as good as the panel of two markers (CA M26, CA M29) in breast cancer diagnostics. Thus it seems that CA M29 is a promising serum tumor marker in breast cancer." @default.
- W162371606 created "2016-06-24" @default.
- W162371606 creator A5029168349 @default.
- W162371606 creator A5042303707 @default.
- W162371606 creator A5084320181 @default.
- W162371606 date "1990-07-01" @default.
- W162371606 modified "2023-09-23" @default.
- W162371606 title "Clinical evaluation of new serum tumor markers CA M26 and CA M29 in patients with primary breast cancer." @default.
- W162371606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2382995" @default.
- W162371606 hasPublicationYear "1990" @default.
- W162371606 type Work @default.
- W162371606 sameAs 162371606 @default.
- W162371606 citedByCount "5" @default.
- W162371606 crossrefType "journal-article" @default.
- W162371606 hasAuthorship W162371606A5029168349 @default.
- W162371606 hasAuthorship W162371606A5042303707 @default.
- W162371606 hasAuthorship W162371606A5084320181 @default.
- W162371606 hasConcept C111683008 @default.
- W162371606 hasConcept C118646709 @default.
- W162371606 hasConcept C121608353 @default.
- W162371606 hasConcept C126322002 @default.
- W162371606 hasConcept C141071460 @default.
- W162371606 hasConcept C142724271 @default.
- W162371606 hasConcept C143998085 @default.
- W162371606 hasConcept C2779013556 @default.
- W162371606 hasConcept C530470458 @default.
- W162371606 hasConcept C71924100 @default.
- W162371606 hasConceptScore W162371606C111683008 @default.
- W162371606 hasConceptScore W162371606C118646709 @default.
- W162371606 hasConceptScore W162371606C121608353 @default.
- W162371606 hasConceptScore W162371606C126322002 @default.
- W162371606 hasConceptScore W162371606C141071460 @default.
- W162371606 hasConceptScore W162371606C142724271 @default.
- W162371606 hasConceptScore W162371606C143998085 @default.
- W162371606 hasConceptScore W162371606C2779013556 @default.
- W162371606 hasConceptScore W162371606C530470458 @default.
- W162371606 hasConceptScore W162371606C71924100 @default.
- W162371606 hasIssue "4" @default.
- W162371606 hasLocation W1623716061 @default.
- W162371606 hasOpenAccess W162371606 @default.
- W162371606 hasPrimaryLocation W1623716061 @default.
- W162371606 hasRelatedWork W1218856796 @default.
- W162371606 hasRelatedWork W2024594909 @default.
- W162371606 hasRelatedWork W2224319365 @default.
- W162371606 hasRelatedWork W2416618117 @default.
- W162371606 hasRelatedWork W2791378469 @default.
- W162371606 hasRelatedWork W2883424930 @default.
- W162371606 hasRelatedWork W3165152487 @default.
- W162371606 hasRelatedWork W3201668145 @default.
- W162371606 hasRelatedWork W3206864557 @default.
- W162371606 hasRelatedWork W350486410 @default.
- W162371606 hasVolume "10" @default.
- W162371606 isParatext "false" @default.
- W162371606 isRetracted "false" @default.
- W162371606 magId "162371606" @default.
- W162371606 workType "article" @default.